arrow
L

Lorenzo Norsa

Vittore Buzzi Children's Hospital
H指数:25
被引数:2,997

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upadacitinib treatment in pediatric Crohn’s disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN

乌帕替尼治疗儿童克罗恩病:欧洲儿科胃肠病与营养学会(ESPGHAN)儿科炎症性肠病波尔托组国际多中心回顾性队列研究的52周结果

2026-09-210
PRE
Understanding the gut microbiota to shape the future of intestinal failure care: a systematic review of the evidence

了解肠道微生物群以塑造肠衰竭护理的未来:一项证据的系统综述

2026-09-090
PRE
Inter-society consensus on the management of acute bloody diarrhea and shiga toxin-producing Escherichia Coli infection in the molecular microbiology era

多学会关于分子微生物学时代急性血性腹泻和志贺毒素产生大肠杆菌感染的共识管理

2026-04-270
OAAI
Long-term effectiveness of dupilumab in eosinophilic esophagitis: Results from the DUPEOETALY Study

Dupilumab在嗜酸性食管炎中的长期疗效:DUPEOETALY研究的结果

2026-04-240
OAAI
Elevation of tTG-IgA Antibodies in a Prospective Cohort of Children at Risk of Celiac Disease: Insights From the CDGEMM Cohort

Celiac disease风险儿童前瞻性队列中tTG-IgA抗体的升高:来自CDGEMM队列的见解

2026-02-010
PRE
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration

更正:10岁及以下儿童炎症性肠病患者的英夫利昔单抗群体药代动力学分析:标签推荐剂量未能达到治疗靶浓度

2025-11-280
OAAI
Characterization of pediatric eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis in a nationwide cohort

除嗜酸性食管炎外,全国队列中儿童嗜酸性胃肠疾病的特征分析

2025-11-010
OAAI
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration

10岁以下儿童炎症性肠病患者的英夫利昔单抗群体药代动力学分析:标签推荐剂量无法达到治疗靶浓度

2025-10-290
OA
Italian SIGENP (Italian Society of gastroenterology, hepatology and pediatric nutrition) registry of pediatric home artificial nutrition: First report

意大利SIGENP(意大利胃肠病学、肝病学和儿科营养学会)儿科家庭人工营养登记系统:首次报告

2025-09-110
PRE
Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry

真实世界中的耐久性及生物制剂停用的风险因素:SIGENP IBD登记研究的成果

2025-09-010
PRE
Update on pediatric inflammatory bowel diseases epidemiology during SARS-CoV-2 outbreak:data from the Italian society of pediatric gastroenterology, epatology and nutrition registry

SARS-CoV-2疫情期间儿童炎症性肠病流行病学进展:意大利儿科胃肠病学、肝病学与营养学会登记注册数据

2025-08-270
PRE
Predictors of response and enteral autonomy in children with short bowel syndrome treated with teduglutide: a real-life multicentre cohort study

teduglutide治疗短肠综合征患儿的反应预测因素和肠内自主性:一项真实世界多中心队列研究

2025-07-080
OA
Transition readiness assessment in adolescents and young adults with chronic intestinal failure on home parenteral nutrition: A descriptive cross-sectional study

慢性肠衰竭接受家庭肠外营养的青少年及青年人群的过渡准备评估:一项描述性横断面研究

2025-04-080
OAAI
Prevalence and outcomes of arthritis in pediatric IBD: A multicenter study from the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition
2025-03-010
PRE
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study

乌帕替尼用于诱导儿童克罗恩病缓解:一项国际多中心回顾性研究

2025-02-081
OAAI